Literature DB >> 3756121

Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes.

J Baldinger, B H Doft, S A Burns, B Johnson.   

Abstract

The retinal toxicity of intravitreally administered amphotericin B was compared in non-vitrectomised versus vitrectomised rabbit eyes. Doses of 5 and 10 micrograms in both groups resulted in transient vitritis but had no effect on electroretinograms. Histopathological examination four weeks after injection showed vitreous cells and minimal areas of retinal necrosis in both groups at 5 or 10 micrograms doses. At these doses vitrectomy did not modify the retinotoxic effects of intravitreally administered amphotericin B. At higher doses marked toxicity was found in both vitrectomised and non-vitrectomised groups.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756121      PMCID: PMC1040794          DOI: 10.1136/bjo.70.9.657

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Vitrectomy in exogenous Candida endophthalmitis.

Authors:  G A Peyman; D W Vastine; J G Diamond
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-10-17

2.  Intravitreal amphotericin B toxicity.

Authors:  E N Souri; W R Green
Journal:  Am J Ophthalmol       Date:  1974-07       Impact factor: 5.258

3.  Toxicity of intravitreal injection of amphotericin B.

Authors:  A J Axelrod; G A Peyman; D J Apple
Journal:  Am J Ophthalmol       Date:  1973-10       Impact factor: 5.258

4.  Intravitreal amphotericin B treatment of Candida endophthamitis.

Authors:  G A Stern; C L Fetkenhour; R B O'Grady
Journal:  Arch Ophthalmol       Date:  1977-01

5.  Toxicity and efficacy of vitrectomy fluids: amphotericin B methyl ester in the treatment of experimental fungal endophthalmitis.

Authors:  M Raichand; G A Peyman; C S West; G Hammond; K Zweig
Journal:  Ophthalmic Surg       Date:  1980-04

6.  Epiretinal membrane formation after vitrectomy.

Authors:  W H Stern; S K Fisher; D H Anderson; J J O'Donnell; P A Erickson; G P Lewis; C J Guerin; G A Borgula; M A McDermott
Journal:  Am J Ophthalmol       Date:  1982-06       Impact factor: 5.258

7.  Bilateral endogenous Aspergillus endophthalmitis.

Authors:  E E Boldrey
Journal:  Retina       Date:  1981       Impact factor: 4.256

8.  Vitrectomy in endophthalmitis. Results of study using vitrectomy, intraocular antibiotics, or a combination of both.

Authors:  A J Cottingham; R K Forster
Journal:  Arch Ophthalmol       Date:  1976-12

9.  Successful treatment of postoperative Candida endophthalmitis in an eye with an intraocular lens implant.

Authors:  C M Gilbert; M A Novak
Journal:  Am J Ophthalmol       Date:  1984-05       Impact factor: 5.258

10.  Vitrectomy in experimental endophthalmitis: Part I-Fungal infection.

Authors:  K Huang; G A Peyman; J McGetrick
Journal:  Ophthalmic Surg       Date:  1979-03
View more
  9 in total

1.  Evaluating retinal toxicity of intravitreal caspofungin in the mouse eye.

Authors:  Deb K Mojumder; Francis A Concepcion; Shil K Patel; Andrew J Barkmeier; Petros E Carvounis; John H Wilson; Eric R Holz; Theodore G Wensel
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

Review 2.  Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis.

Authors:  G A Stern
Journal:  Trans Am Ophthalmol Soc       Date:  1993

3.  Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.

Authors:  Joseph M Harrison; Randolph D Glickman; Charles S Ballentine; Yolanda Trigo; Melanie A Pena; Pearl Kurian; Laura K Najvar; Neeru Kumar; Ankit H Patel; William E Sponsel; John R Graybill; William C Lloyd; Margaret M Miller; Gianmarco Paris; Fernando Trujillo; Aaron Miller; Robert Melendez
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

Review 4.  Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.

Authors:  Prit Lakhani; Akash Patil; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2018-11-08       Impact factor: 2.671

5.  Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.

Authors:  Hua Gao; Mark Pennesi; Kekul Shah; Xiaoxi Qiao; Seenu M Hariprasad; William F Mieler; Samuel M Wu; Eric R Holz
Journal:  Trans Am Ophthalmol Soc       Date:  2003

6.  The effect of chemical stability and purification of perfluorocarbon liquids in experimental extended-term vitreous substitution.

Authors:  M Velikay; U Stolba; A Wedrich; Y Li; P Datlinger; S Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-01       Impact factor: 3.117

7.  Pharmacokinetics and safety of intravitreal caspofungin.

Authors:  Ying-Cheng Shen; Chiao-Ying Liang; Chun-Yuan Wang; Keng-Hung Lin; Min-Yen Hsu; Hon-Leung Yuen; Li-Chen Wei
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

Review 8.  A Review of Antimicrobial Therapy for Infectious Uveitis of the Posterior Segment.

Authors:  Ahmed B Sallam; Kyle A Kirkland; Richard Barry; Mohamed Kamel Soliman; Tayyeba K Ali; Sue Lightman
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018

Review 9.  Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments.

Authors:  Alisha Khambati; Robert Emery Wright; Susmita Das; Shirisha Pasula; Alejandro Sepulveda; Francis Hernandez; Mamta Kanwar; Pranatharthi Chandrasekar; Ashok Kumar
Journal:  J Fungi (Basel)       Date:  2022-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.